Posted On: 07/13/2016 5:18:50 PM
Post# of 72445
Re: grizzlyman #25196
5 clinical trials, market cap 158 million. So Prurisol, with its billion-dollar market, is currently valued at around 32 million. Every one of the other drugs has a market worth more than 320 million upon approval.
It's a screaming buy. The company has made great strides forward just in the past couple of weeks in terms of company development. I remind you that we've seen both Leo and Dr. B. referring to "interest" on the part of bigger companies.
Reading tea leaves is fun but not usually very accurate. We could have some sort of great news dropped in our laps tomorrow, or next quarter. No way of telling, but I'm certainly not discouraged that the new CEO is getting ducks in a row and getting things going the way HE wants to run things. And kudos to Leo and Dr. Menon for letting him do so.
It's a screaming buy. The company has made great strides forward just in the past couple of weeks in terms of company development. I remind you that we've seen both Leo and Dr. B. referring to "interest" on the part of bigger companies.
Reading tea leaves is fun but not usually very accurate. We could have some sort of great news dropped in our laps tomorrow, or next quarter. No way of telling, but I'm certainly not discouraged that the new CEO is getting ducks in a row and getting things going the way HE wants to run things. And kudos to Leo and Dr. Menon for letting him do so.
(0)
(0)
